| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.3 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |